MIACALCIN
Live / Registered — Registered and renewed (as of 10 May 2022)
What this means for you
Registered since 27 Oct 1992. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Oct 2022).
Record
- Serial number
- 74255027
- Registration number
- 1726984
- Mark type
- Word mark
- Filed
- 13 Mar 1992
- Published for opposition
- 04 Aug 1992
- Registered
- 27 Oct 1992
- Next maintenance due
- 27 Oct 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals used for the treatment of Paget's disease, osteoporosis and hypercalcemia
Owner
- NOVARTIS AG, Basel, CH
- SANDOZ AG (SANDOZ LTS., SANDOZ S.A.), CH-4002 Basle, CH
- SANDOZ PHARMACEUTICALS CORPORATION, E. Hanover, NJ, US
- SANDOZ PHARMACEUTICALS CORPORATION, E. Hanover, NJ, US
- SANDOZ PHARMACEUTICALS CORPORATION, E. Hanover, NJ, US
Prosecution history
- 10 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 May 2022 — REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
- 10 May 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jan 2022 — TEAS SECTION 8 & 9 RECEIVED
- 27 Oct 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Dec 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 Dec 2012 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 07 Dec 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 07 Dec 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Nov 2012 — TEAS SECTION 8 & 9 RECEIVED
- 03 Mar 2010 — REVIEW OF CORRESPONDENCE COMPLETE
- 02 Mar 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Mar 2008 — CASE FILE IN TICRS